Covidien has won Canadian approval for its imaging agent Cardiolite for diagnosing heart disease. The Bristol-Myers Squibb generic drug is used in diagnostic stress tests of the heart. As a result of the approval by Canadian authorities, Covidien said it expects its test to be available in the country as early as this summer. (Click here for more)
“Covidien Gets Canadian OK For Generic Cardiolite” – Boston Globe (7/6/09)
Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com
